Inventor
TAKAHIRO ISHIGURO
Inventor
JP
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12NMicroorganisms or enzymes16%
A01KAnimal husbandry11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
12,522,669Cytotoxicity-inducing therapeutic agent202612,479,929Cytotoxicity-inducing therapeutic agent202511,793,180Gene-modified mouse expressing human GPC3 polypeptide202311,612,149Non-human animal having human CD3 gene substituted for endogenous CD3 gene202311,505,605T cell-redirected antigen-binding molecule for cells having immunosuppression function2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (5)· patent assignee history
2022Patents assigned to UNIV OSAKA (1)· patent assignee history
2022–2026Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO LTD | 5 | 2022–2026 |
| UNIV OSAKA | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 5 | 2022–2026 |